Infectious complications of lung cancer Journal Article
| Author: | Seo, S. K. |
| Article Title: | Infectious complications of lung cancer |
| Abstract: | Although patients with lung cancer have benefited from advances in diagnostic techniques, surgery, chemotherapy, and radiation, infection frequently complicates the course of cancer treatment. Infection may be caused by the tumor itself, by antineoplastic therapy, or by supportive care measures. Recognition of risk factors for infection is critical. The relationship between an underlying immune defect and certain infections is well documented. Diagnosis may be complicated by the paucity of signs and symptoms or by an atypical presentation. Prompt institution of empiric antimicrobial therapy is usually warranted, particularly in life-threatening infections. This review will focus on the epidemiology, diagnosis, and management of particular infections that can occur in patients with lung cancer. |
| Keywords: | cancer chemotherapy; treatment outcome; treatment response; antibiotic agent; clinical feature; disease course; mortality; neutropenia; review; cisplatin; doxorubicin; advanced cancer; cancer risk; disease classification; drug efficacy; multimodality cancer therapy; antineoplastic agents; gemcitabine; paclitaxel; cancer radiotherapy; combined modality therapy; cancer staging; antineoplastic agent; diagnostic procedure; carboplatin; unindexed drug; immune system; infection; nephrotoxicity; bone marrow suppression; diagnosis, differential; etoposide; esophagitis; lung non small cell cancer; nausea; neuropathy; vomiting; lung neoplasms; differential diagnosis; incidence; morbidity; aciclovir; cyclophosphamide; vincristine; herpes zoster; radiation injury; ifosfamide; docetaxel; irinotecan; fever; lung tumor; patient care; lung small cell cancer; antiinfective agent; laboratory test; radiation injuries; thorax radiography; drug bioavailability; medical documentation; immune deficiency; immunocompromised host; corticosteroid; lung surgery; microbiology; navelbine; lung infection; wound infection; influenza vaccine; influenza; alopecia; disease exacerbation; caspofungin; fluconazole; hearing loss; cost benefit analysis; aspiration pneumonia; electrolyte disturbance; pyrrole derivative; itraconazole; sustained release preparation; lung tuberculosis; emphysema; esophagus candidiasis; famciclovir; amoxicillin plus clavulanic acid; valaciclovir; community acquired pneumonia; nystatin; thrush; amphotericin b; chronic bronchitis; cefaclor; cefuroxime axetil; lower respiratory tract infection; lung abscess; mouth injury |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 19 |
| Issue: | 2 |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2005-02-01 |
| Start Page: | 185 |
| End Page: | 194 |
| Language: | English |
| PUBMED: | 15770889 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 2" - "Export Date: 24 October 2012" - "CODEN: OCLGE" - "Source: Scopus" |
